Senior insider sale
Chief Medical Officer at PROTAGONIST THERAPEUTICS, INC — senior position signals high conviction
$2.11M
25.38K shares
What this filing means
MOLINA ARTURO MD plans to sell 25.38K shares of PROTAGONIST THERAPEUTICS, INC valued at approximately $2.11M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/23/2026ACC: 0001950047-26-000655
Officer· Chief Medical Officer
Since Jan 2026
25.38K
Shares to sell
$2.11M
Approx. market value
13.15K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months4
Restricted Stock
Not Applicable
1/15/2026
4.80KRestricted Stock
Not Applicable
1/15/2026
650.00Restricted Stock
Not Applicable
1/15/2026
5.10KRestricted Stock
Not Applicable
11/15/2025
2.60KTotal acquired13.15K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/15/2026 | Restricted Stock Not Applicable | 4.80K | — |
1/15/2026 | Restricted Stock Not Applicable | 650.00 | — |
1/15/2026 | Restricted Stock Not Applicable | 5.10K | — |
11/15/2025 | Restricted Stock Not Applicable | 2.60K | — |
| Total | 13.15K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
9.51K
Market value
$784.7K
1/20/2026
—Completed
Units to sell
2.71K
Market value
$229.9K
11/18/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
13.15K
Market value
$1.10M
1/23/2026
Total
Units
25.38K
Value
$2.11M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/20/2026 | 9.51K | $784.7K | — | Completed |
11/18/2025 | 2.71K | $229.9K | — | Completed |
| Planned — Approximate Date | ||||
1/23/2026 | 13.15K | $1.10M | NASDAQ | Planned |
| Total | 25.38K | $2.11M | ||